Transforming growth factor-beta signaling in cancer.

Published

Journal Article (Review)

Transforming growth factor (TGF-beta) is a multifunctional polypeptide implicated in the regulation of a variety of cellular processes including growth, differentiation, apoptosis, adhesion, and motility. Abnormal activation or inhibition of these TGF-beta regulated processes is implicated in many diseases, including cancer. Cancers can develop through selective exploitation of defects in TGF-beta signaling that occur at several different levels in the pathway. The TGF-beta signal transduction cascade is initiated when TGF-beta binds to transmembrane receptors. The TGF-beta receptors then phosphorylate and activate Smad proteins, which transduce the signal from the cytoplasm to the nucleus. In the nucleus, Smads can bind directly to DNA and cooperate with other transcription factors to induce transcription of TGF-beta target genes. Mutations in target genes, Smads, or the TGF-beta receptor are associated with certain human cancers.

Full Text

Duke Authors

Cited Authors

  • Rich, J; Borton, A; Wang, X

Published Date

  • February 15, 2001

Published In

Volume / Issue

  • 52 / 4

Start / End Page

  • 363 - 373

PubMed ID

  • 11170295

Pubmed Central ID

  • 11170295

International Standard Serial Number (ISSN)

  • 1059-910X

Digital Object Identifier (DOI)

  • 10.1002/1097-0029(20010215)52:4<363::AID-JEMT1021>3.0.CO;2-F

Language

  • eng

Conference Location

  • United States